Skip to main content
. 2010 Jul 13;15(3):259–263. doi: 10.1111/j.1542-474X.2010.00373.x

Table 1.

Baseline Clinical and Echocardiographic Characteristics of Study Population

Obese Subjects (n = 40) Controls (n = 20) P Value
Sex (male %) 32 (80)  15 (75) NS
Age (years) 54 ± 10 50 ± 9  NS
BMI (Kg/m2) 29.4 ± 3.0  21.5 ± 2.0  <0.01
Hypertension (%) 13 (32.5)  5 (25) NS
Diabetes mellitus (%)  5 (12.5)  2 (10) NS
SBP (mmHg) 133 ± 18  127 ± 16  NS
DBP (mmHg) 80 ± 10 83 ± 11 NS
Fasting glucose (mmol/L) 5.87 ± 1.84 5.31 ± 1.90 NS
Total cholesterol (mmol/L) 4.9 ± 0.9 5.0 ± 0.5 NS
LDL cholesterol (mmol/L) 2.9 ± 0.8 3.0 ± 0.6 NS
HDL cholesterol (mmol/L) 1.2 ± 0.3 1.5 ± 0.4 NS
Triglycerides (mmol/L) 1.8 ± 0.8 1.4 ± 0.7 NS
LAD (mm) 37.6 ± 7.3  29.6 ± 4.8  <0.01
LVEDD (mm) 45.5 ± 3.6  44.1 ± 3.2  NS
IVST (mm) 9.8 ± 2.7 8.0 ± 1.9 <0.05
LVEF (%) 58.8 ± 6.9  65.2 ± 6.5  NS
Medications
 Statin (%) 11 (27.5)  6 (30) NS
 ACEIs or ARBs (%)  7 (17.5)  3 (15) NS
 CCBs (%) 8 (20)   3 (15) NS
 Diuretics (%) 3 (7.5) 1 (5) NS

Bold indicates a significant difference between the two groups. BMI = body mass index; NS = not significant; SBP = Systolic blood pressure; DBP = diastolic blood pressure; LDL‐c, low‐density lipoprotein; HDL‐c, high‐density lipoprotein; LAD = left atrial diameter; LVEDD = left ventricular end‐diastolic diameter; LVEF = left ventricular ejection fraction; IVST = interventricular septum thickness ACEIs = angiotensin‐converting enzyme inhibitors; ARBs = angiotensin receptor blockers; CCBs = calcium channel blockers.